Mometasone furoate gel - EMS

Drug Profile

Mometasone furoate gel - EMS

Alternative Names: Mometasone furoate monohydrate - EMS

Latest Information Update: 14 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator EMS
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Glucocorticoids; Pregnadienediols; Skin disorder therapies
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Allergic rhinitis

Most Recent Events

  • 14 Nov 2016 Chemical structure information added
  • 01 Nov 2016 Clinical trials in Allergic rhinitis in Brazil (Intranasal) before November 2016
  • 01 Nov 2016 EMS plans a phase III trial for Allergic rhinitis (In adolescents, In adults) in Brazil (Intranasal, Gel) (NCT02953379)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top